During the past decade, University of Tennessee, Memphis Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Tennessee, Memphis Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 31 trials, followed by "Radiation Therapy Oncology Group" with 24 trials sponsored, "Eastern Cooperative Oncology Group" with 6 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "National Cancer Institute (NCI)" with 4 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tennessee, Memphis Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University of Tennessee, Memphis Cancer Center" are "Lung Cancer" (11 trials), "Leukemia" (9 trials), "Prostate Cancer" (8 trials), "Lymphoma" (7 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "University of Tennessee, Memphis Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Tennessee, Memphis Cancer Center" are "Drug" (52 trials), "Radiation" (28 trials), "Procedure" (16 trials), "Biological" (15 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (21 trials), "doxorubicin hydrochloride" (10 trials), "paclitaxel" (10 trials), "cyclophosphamide" (8 trials) and "carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of Tennessee, Memphis Cancer Center" are 60 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "University of Tennessee, Memphis Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in University of Tennessee, Memphis Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Tennessee, Memphis Cancer Center, 10 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".